Yvette H. Matser

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Erratum: Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

Erratum: Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

Journal: JCO precision oncology

Published: July 16, 2026

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

Journal: JCO precision oncology

Published: July 01, 2026

Effect of MYCN Amplification on Tumor Response and Recurrence in Patients With Stage IV Neuroblastoma.

Effect of MYCN Amplification on Tumor Response and Recurrence in Patients With Stage IV Neuroblastoma.

Journal: JCO precision oncology

Published: March 12, 2026

Urinary Catecholamines Predict Relapse During Complete Remission in High-Risk Neuroblastoma.

Urinary Catecholamines Predict Relapse During Complete Remission in High-Risk Neuroblastoma.

Journal: JCO precision oncology

Published: February 21, 2025

Validation of an LC-MS/MS method for urinary homovanillic and vanillylmandelic ACIDS and application to the diagnosis of neuroblastoma.

Validation of an LC-MS/MS method for urinary homovanillic and vanillylmandelic ACIDS and application to the diagnosis of neuroblastoma.

Journal: Journal of mass spectrometry and advances in the clinical lab

Published: March 13, 2024

Case series on clinical applications of liquid biopsy in pediatric solid tumors: towards improved diagnostics and disease monitoring.

Case series on clinical applications of liquid biopsy in pediatric solid tumors: towards improved diagnostics and disease monitoring.

Journal: Frontiers in oncology

Published: April 20, 2023

Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine.

Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 15, 2023

Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy.

Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy.

Journal: Cancer cell

Published: February 15, 2023

Optimising urinary catecholamine metabolite diagnostics for neuroblastoma.

Optimising urinary catecholamine metabolite diagnostics for neuroblastoma.

Journal: Pediatric blood & cancer

Published: November 04, 2022

Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With Neuroblastoma.

Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With Neuroblastoma.

Journal: JCO precision oncology

Published: January 27, 2022

Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics.

Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics.

Journal: Cancer science

Published: November 01, 2021

Transmission of breast cancer by a single multiorgan donor to 4 transplant recipients.

Transmission of breast cancer by a single multiorgan donor to 4 transplant recipients.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: November 14, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026